Sandoz settles U.S. generic drug litigation for $450 million, reaffirms outlook
Sandoz settles U.S. generic drug litigation for $450 million, reaffirms outlook
6.0Significance
2 sources6.0Source trust
Top stories · Organization
SDZ
Connected in the knowledge graph
OrganizationSandoz's U.SOrganizationSandoz Group AGOrganizationInvesting.comOrganizationU.SOrganizationSixOrganizationUnderOrganizationSandoz
Latest coverage · 1 topic
Where SDZ shows up